Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship
- Nikos Papadimitriou 1, Nabila Kazmi 2,3, Konstantinos K Tsilidis 4,5, Rebecca C Richmond 2,3, Brigid M Lynch 6,7,8, Benedetta Bendinelli 9, Fulvio Ricceri 10, Maria-Jose Sánchez 11,12,13, Camino Trobajo-Sanmartín 13,14,15, Paula Jakszyn 16,17, Vittorio Simeon 18, Gianluca Severi 19,20, Vittorio Perduca 20,21, Therese Truong 20, Pietro Ferrari 1, Pekka Keski-Rahkonen 1, Elisabete Weiderpass 22, Fabian Eichelmann 23,24, Matthias B Schulze 23,25, Verena Katzke 26, Renée Turzanski Fortner 26,27, Alicia K Heath 5, Dagfinn Aune 5,27,28, Rhea Harewood 29, Christina C Dahm 30, Adrian Llorente 31, Marc J Gunter 1,5, Neil Murphy 1, Sarah J Lewis 2,3
- Nikos Papadimitriou 1, Nabila Kazmi 2,3, Konstantinos K Tsilidis 4,5
- 1Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
- 2MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
- 3Population Health Sciences, The Medical School, University of Bristol, Bristol, United Kingdom.
- 4Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
- 5Cancer Epidemiology and Prevention Research Unit, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
- 6Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
- 7Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
- 8Physical Activity Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
- 9Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Cinical Network (ISPRO), Florence, Italy.
- 10Department of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health (C-BEPH), University of Turin, Turin, Italy.
- 11Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
- 12Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
- 13Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
- 14Instituto de Salud Pública y Laboral de Navarra, Pamplona, Spain.
- 15Navarre Institute for Health Research (IdiSNA), Pamplona, Spain.
- 16Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
- 17Blanquerna School of Health Sciences, Ramon Llull University, Barcelona, Spain.
- 18Unit of Medical Statistics, Department of Mental and Physical Health and Preventive Medicine, University of Campania, Naples, Italy.
- 19Department of Statistics, Computer Science, Applications "G. Parenti", University of Florence, Florence, Italy.
- 20Paris-Saclay University, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.
- 21Université Paris Cité, CNRS, MAP5, Paris, France.
- 22International Agency for Research on Cancer, Lyon, France.
- 23Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
- 24German Center for Diabetes Research (DZD), Neuherberg, Germany.
- 25Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
- 26Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 27Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
- 28Department of Nutrition, Oslo New University College, Oslo, Norway.
- 29Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
- 30Department of Public Health, Aarhus University, Aarhus Centrum, Denmark.
- 31Subdirection of Public Health of Guipuzcoa, San Sebastián, Spain.
- 0Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
|
January 30, 2025
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Higher physical activity (PA) is linked to lower colorectal cancer risk. The metabolite phosphatidylcholine ae C34:3 (PC ae C34:3) partially explains this association, offering insights into cancer prevention.
Area Of Science
- Metabolomics
- Cancer Epidemiology
- Physical Activity Research
Background
- Growing evidence links higher physical activity (PA) to reduced colorectal cancer (CRC) risk.
- The specific biological pathways, particularly the role of circulating metabolites, mediating this relationship are not fully understood.
Purpose Of The Study
- To investigate the mediating role of the metabolome in the association between physical activity and colorectal cancer risk.
- To identify specific metabolites that may explain how physical activity influences CRC risk.
Main Methods
- Utilized targeted metabolomics data from 6,055 participants in the European Prospective Investigation into Cancer and Nutrition cohort.
- Employed mediation analyses within a nested case-control study (1,585 cases, 1,585 controls) to assess metabolite mediation of the PA-CRC association.
Main Results
- Physical activity was inversely associated with colorectal cancer risk (OR 0.90).
- PA levels correlated with 24 circulating metabolites, notably phosphatidylcholine acyl-alkyl C34:3 (PC ae C34:3) and lysophosphatidylcholine acyl C18:2.
- PC ae C34:3 partially mediated the PA-CRC association, accounting for 7.4% of the effect.
Conclusions
- The metabolite PC ae C34:3 partially mediates the inverse association between physical activity and colorectal cancer.
- Further research with enhanced PA assessment and broader metabolomic profiling is warranted to fully elucidate these mechanisms.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

